Laurent Désaubry

14PUBLICATIONS
54CO-AUTHORS
Molecular targetsProteomics and intermolecular interactions (excl. medical proteomics)Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 24, 2026
Development of capsaicin-derived prohibitin ligands to modulate the Aurora kinase A/PHB2 interaction and mitophagy in cancer cells.

Amel Djehal, Claire Caron, Deborah Giordano

|Apr 02, 2024
Loss of prohibitin 2 in Schwann cells dysregulates key transcription factors controlling developmental myelination.

Emma R Wilson, Gustavo Della-Flora Nunes, Shichen Shen

|Jul 29, 2023
Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies.

Ahmad Najem, Mohammad Krayem, Serena Sabbah

|Apr 21, 2023
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.

Anne Largeot, Vanessa Klapp, Elodie Viry

|Feb 11, 2023
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma.

Sara M Steinmann, Anabel Sánchez-Martín, Elisabeth Tanzer

|Jan 21, 2023
Triazine-Based Small Molecules: A Potential New Class of Compounds in the Antifungal Toolbox.

Karen A Conrad, Hyunjeong Kim, Mohammad Qasim

Pageof 3

Frequent Collaborators

3 joint publications

Dong Wang

2 joint publications

Peng Yu

1 joint publications

Krishnaraj Rajalingam

1 joint publications

Canan G Nebigil